Target intelligence / Profile preview

Protozoan mitochondrial respiratory chain

Molecular classification
Enzyme complex, Electron transport chain, Metabolic pathway
01

Overview

The protozoan mitochondrial respiratory chain refers to a multi-protein enzyme system located in the inner membrane of mitochondria in protozoan parasites. It consists primarily of four large complexes (I–IV) and associated molecules (such as ubiquinone and cytochrome c) that mediate the transfer of electrons from metabolic substrates to molecular oxygen, a process coupled with the pumping of protons across the membrane to generate a proton motive force. This electrochemical gradient is harnessed by ATP synthase to drive ATP synthesis, forming the basis of oxidative phosphorylation and energy metabolism in eukaryotic cells. In protozoan parasites from groups such as Apicomplexa, unique adaptations in the composition and structure of these complexes provide potential therapeutic targets that differ from their mammalian counterparts. Inhibitors targeting the protozoan mitochondrial electron transport chain, such as atovaquone against Plasmodium and Toxoplasma, have demonstrated antiparasitic efficacy by blocking electron transfer, collapsing the proton gradient, and inhibiting ATP generation, ultimately resulting in parasite death. Selectivity and safety remain a concern due to similarities with the mammalian mitochondrial respiratory chain.

Other names
Protozoan mitochondrial electron transport chainProtozoan oxidative phosphorylation chainProtozoan mETC
02

Mechanism of action

Inhibition of electron transport chain complexes (e.g., complex III inhibition by atovaquone); Disruption of proton gradient and ATP production

03

Biological functions

Cellular energy metabolismOxidative phosphorylationATP synthesisMaintenance of mitochondrial membrane potentialElectron transport
04

Disease associations

Infection (as a drug target in protozoan parasites)
05

Safety considerations

Potential off-target toxicity to mammalian mitochondrial respiratory chainSelectivity required to avoid human mitochondrial dysfunction
06

Interacting drugs

Atovaquone

2 more in the full profile.

Beyond the preview

Go deeper on Protozoan mitochondrial respiratory chain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protozoan mitochondrial respiratory chain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call